Sumitomo Pharma Switzerland (SMPS) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Aeschengraben 27, Basel,bs 4051,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Basel, BS
Sumitomo Pharma Switzerland Questions
Sumitomo Pharma Switzerland's website is https://www.ch.sumitomo-pharma.com/
Sumitomo Pharma Switzerland's LinkedIn profile is https://ch.linkedin.com/company/sumitomo-pharma-switzerland
Sumitomo Pharma Switzerland has
22 employees.
View email and phone details for 22
employees at Sumitomo Pharma Switzerland.
Sumitomo Pharma Switzerland's industry is
Pharmaceutical Manufacturing
Sumitomo Pharma Switzerland's top competitors are
Italfarmaco S.p.a.,
Roche,
Sumitomo Pharma America, Inc.,
Sarepta Therapeutics,
Daiichi Sankyo Europe Gmbh,
Sumitomo Corporation,
Blueprint Medicines,
Myovant Sciences,
Novartis,
Ultragenyx.
Sumitomo Pharma Switzerland's categories are Pharmaceutical Manufacturing
Sumitomo Pharma Switzerland's founding year is 2023
